Profil
Stefan Proniuk worked as a Scientist at CIMA Labs, Inc. from 2000 to 2002.
He then worked as a Senior Manager-Pharmaceutical Technologies at Neurocrine Biosciences, Inc. from 2002 to 2008.
From 2008 to 2017, he served as the Chief Development Officer at Arno Therapeutics, Inc. Dr. Proniuk holds an MBA from San Diego State University and a doctorate from the University of Arizona.
Anciens postes connus de Stefan Proniuk
| Sociétés | Poste | Fin |
|---|---|---|
| ARNO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2017 |
| NEUROCRINE BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/2008 |
CIMA Labs, Inc.
 CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Corporate Officer/Principal | 01/01/2002 |
Formation de Stefan Proniuk
| University of Arizona | Doctorate Degree |
| San Diego State University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARNO THERAPEUTICS, INC. | Health Technology |
| NEUROCRINE BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
CIMA Labs, Inc.
CIMA Labs, Inc. Pharmaceuticals: OtherHealth Technology CIMA Labs, Inc. develops and manufactures prescription and over-the-counter pharmaceutical products using fast-dissolve drug delivery technologies. It develops orally disintegrating technology based OraSolv and DuraSolv tablets. It also develops tranmucosal tablets that can be administered sublingually. The company is headquartered in Brooklyn Park, MN. | Health Technology |
